• March 2022: Lu-177 vipivotide tetraxetan & Ga-68 gozetotide receive FDA approval for prostate cancer
  • May 2020: Cerianna (F-18 fluoroestradiol) receives FDA approval for ER+ breast cancer imaging
  • Access the latest issues of the JNM and the JNMT
  • Learn about the Facilitating Innovative Nuclear Diagnostics (FIND) Act
  • March 2021:SNMMI Statement on COVID-19 and Ventilation/Perfusion (V/Q) Lung Studies
  • March 2021:SNMMI Statement: The Effect of COVID-19 Vaccination on FDG PET/CT

2025 Fall Annual Meeting

Make plans to join us in Kansas City for the 2025 Annual Meeting: Sept. 26-28, 2025 at the same Embassy Suites Kansas City Int'l Airport Hotel!



Exhibitor Forms

2025 Exhibitor Contract

2025 Meeting Prospectus

2025 Commercial Support Agreement

2025 Sponsorship Form